BioCryst Pharmaceuticals (BCRX) Posted Q2 49.5% Revenue Surge
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is a biotechnology company dedicated to discovering and developing innovative oral therapies for rare…
Browsing Tag